Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE

Why are US steel tariffs doubling? How will Ukraine drone strikes impact Russia? What caused Tesla Superchargers removal in New Jersey? Why is OpenAI's CEO pivotal now? How are tariffs affecting Walmart and Target prices? What’s behind the surge in Nvidia stock? Why was NASA nominee Jared Isaacman withdrawn?

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE

investors.modernatx.com/news/news-details/2025/Moderna-Receives-U-S--FDA-Approval-for-COVID-19-Vaccine-mNEXSPIKE/default.aspx

mNEXSPIKE becomes Moderna's third FDA-approved product
CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mNEXSPIKE® (mRNA-1283), a new vaccine against COVID-19, for use in all adults…

This story appeared on investors.modernatx.com, 2025-05-31 10:33:39.023000.